MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

“The new ACCESS25 delivery microcatheter has not only proven its tracking capabilities in numerous procedures,” says Dr. Scott McPherson, an interventional neuroradiologist at St. Dominic’s Hospital, “but it has also showcased stability amidst procedural complexities in aneurysm management.”

“The CD Horizon ModuLeX™ spinal system has greatly improved my overall workflow for complex deformity surgery. Its modular design allows me to develop patient-specific, adaptable solutions to match the patient’s anatomy. With ModuLeX™, not only can you see more, but you can do more; the system allows me to be flexible in my approach. In my hands, the system improves my surgical efficiency and visibility of the surgical area, which helps me deliver a better standard of help for pediatric patients” said Dr. Nicholas Fletcher, Children’s Healthcare of Atlanta at Scottish Rite and Medtronic consultant.

“Our mission at AVI is to improve vascular access outcomes for all patients,” said James Biggins, CEO of Access Vascular. “We’re proud to partner with Recon Supply to bring our MIMIX® catheter family to the FSS contract and DAPA. This addition ensures that the people who serve our nation have access to the gold standard in vascular care.”

The Wyss Center has granted BrainScape Medical an exclusive license for Epios®, a cutting-edge platform designed for continuous, long-term brain activity monitoring. Epios® offers a minimally invasive solution for diagnosing and treating neurological disorders, with first-in-human trials demonstrating promising results.

Dr. Peter Forsell, inventor of RefluxStop™, CEO and founder of Implantica, says, “Approximately 15% of the adult population in Spain suffer from GERD¹ with countless patients resigned to live with the painful symptoms because they are poorly treated by existing methods or not candidates for the mainstream anti-reflux surgical treatments.”

“We’re excited about the positive feedback we’ve received from early users of the Pounce XL System,” said Gary Maharaj, President and Chief Executive Officer of Surmodics. “The addition of this larger-profile device to the Pounce Thrombectomy Platform fulfills our goal of providing physicians a standalone solution for rapid removal of acute or chronic peripheral arterial clot throughout the lower extremity. With hospitals under growing pressure to reduce costs, we believe the standalone Pounce Thrombectomy Platform may help reduce the need for hospitalizations and follow-up procedures.”